These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 34773243)
1. Current and Emerging Applications of Droplet Digital PCR in Oncology: An Updated Review. Olmedillas-López S; Olivera-Salazar R; García-Arranz M; García-Olmo D Mol Diagn Ther; 2022 Jan; 26(1):61-87. PubMed ID: 34773243 [TBL] [Abstract][Full Text] [Related]
2. Current and Emerging Applications of Droplet Digital PCR in Oncology. Olmedillas-López S; García-Arranz M; García-Olmo D Mol Diagn Ther; 2017 Oct; 21(5):493-510. PubMed ID: 28477149 [TBL] [Abstract][Full Text] [Related]
3. Monitoring of urothelial cancer disease status after treatment by digital droplet PCR liquid biopsy assays. Pritchard JJG; Hamilton G; Hurst CD; Fraser S; Orange C; Knowles MA; Jones RJ; Leung HY; Iwata T Urol Oncol; 2020 Sep; 38(9):737.e1-737.e10. PubMed ID: 32532529 [TBL] [Abstract][Full Text] [Related]
4. Detection of circulating tumor DNA by digital droplet PCR in resectable lung cancer as a predictive tool for recurrence. Gassa A; Fassunke J; Schueten S; Kuhlmann L; Scherer M; Qien J; Zhao Y; Michel M; Loeser H; Wolf J; Buettner R; Doerr F; Heldwein M; Hagmeyer L; Frank K; Merkelbach-Bruse S; Quaas A; Bruns C; Hekmat K; Weiss J; Wahlers T; Alakus H Lung Cancer; 2021 Jan; 151():91-96. PubMed ID: 33257044 [TBL] [Abstract][Full Text] [Related]
5. Validation of a next-generation sequencing assay for the detection of EGFR mutations in cell-free circulating tumor DNA. Stitz R; Buder A; Silye R; Baumgartner B; Pühringer F; Filipits M; Oberndorfer E; Heitzer E Exp Mol Pathol; 2021 Dec; 123():104685. PubMed ID: 34560086 [TBL] [Abstract][Full Text] [Related]
6. Optimized (Pre) Analytical Conditions and Workflow for Droplet Digital PCR Analysis of Cell-Free DNA from Patients with Suspected Lung Carcinoma. de Kock R; Deiman B; Kraaijvanger R; Scharnhorst V J Mol Diagn; 2019 Sep; 21(5):895-902. PubMed ID: 31229652 [TBL] [Abstract][Full Text] [Related]
7. Detection of circulating tumor DNA (ctDNA) by digital droplet polymerase chain reaction (dd-PCR) in liquid biopsies. Valpione S; Campana L Methods Enzymol; 2019; 629():1-15. PubMed ID: 31727235 [TBL] [Abstract][Full Text] [Related]
8. Liquid biopsy approaches for pleural effusion in lung cancer patients. Baburaj G; Damerla RR; Udupa KS; Parida P; Munisamy M; Kolesar J; Rao M Mol Biol Rep; 2020 Oct; 47(10):8179-8187. PubMed ID: 33029702 [TBL] [Abstract][Full Text] [Related]
9. Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics. van Ginkel JH; van den Broek DA; van Kuik J; Linders D; de Weger R; Willems SM; Huibers MMH Cancer Med; 2017 Oct; 6(10):2297-2307. PubMed ID: 28940814 [TBL] [Abstract][Full Text] [Related]
10. Recent Technologies towards Diagnostic and Therapeutic Applications of Circulating Nucleic Acids in Colorectal Cancers. Chung J; Xiao S; Gao Y; Soung YH Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201393 [TBL] [Abstract][Full Text] [Related]
11. Monitoring Melanoma Using Circulating Free DNA. Diefenbach RJ; Lee JH; Rizos H Am J Clin Dermatol; 2019 Feb; 20(1):1-12. PubMed ID: 30374893 [TBL] [Abstract][Full Text] [Related]
12. Developing Ultrasensitive Library-Aliquot-Based Droplet Digital PCR for Detecting T790M in Plasma-Circulating Tumor DNA of Non-small-Cell-Lung-Cancer Patients. Yang K; Li J; Zhao J; Ren P; Wang Z; Wei B; Dong B; Sun R; Wang X; Groen HJM; Ma J; Guo Y Anal Chem; 2018 Oct; 90(19):11203-11209. PubMed ID: 30156405 [TBL] [Abstract][Full Text] [Related]
13. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients. Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141 [TBL] [Abstract][Full Text] [Related]
14. [Clinical Value of Droplet Digital PCR and Super-ARMS Detection of Epidermal Growth Factor Receptor Gene Mutation in Plasma Circulating Tumor DNA of Patients with Advanced Lung Adenocarcinoma]. Cao Z; Wang J; Qin N; Li K; Lv J; Wang J; Yang X; Li X; Zhang H; Zhang Q; Long H; Shu C; Ma L; Zhang S Zhongguo Fei Ai Za Zhi; 2020 Feb; 23(2):84-90. PubMed ID: 32093452 [TBL] [Abstract][Full Text] [Related]
16. An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues. Ono Y; Sugitani A; Karasaki H; Ogata M; Nozaki R; Sasajima J; Yokochi T; Asahara S; Koizumi K; Ando K; Hironaka K; Daito T; Mizukami Y Mol Oncol; 2017 Oct; 11(10):1448-1458. PubMed ID: 28691390 [TBL] [Abstract][Full Text] [Related]
17. Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study. Zivanovic Bujak A; Weng CF; Silva MJ; Yeung M; Lo L; Ftouni S; Litchfield C; Ko YA; Kuykhoven K; Van Geelen C; Chandrashekar S; Dawson MA; Loi S; Wong SQ; Dawson SJ PLoS Med; 2020 Oct; 17(10):e1003363. PubMed ID: 33001984 [TBL] [Abstract][Full Text] [Related]
18. Tumor-specific genetic variants can be detected in circulating cell-free DNA of malignant pleural mesothelioma patients. Hylebos M; Op de Beeck K; Pauwels P; Zwaenepoel K; van Meerbeeck JP; Van Camp G Lung Cancer; 2018 Oct; 124():19-22. PubMed ID: 30268460 [TBL] [Abstract][Full Text] [Related]
19. Plasma vs. serum in circulating tumor DNA measurement: characterization by DNA fragment sizing and digital droplet polymerase chain reaction. Lee JS; Kim M; Seong MW; Kim HS; Lee YK; Kang HJ Clin Chem Lab Med; 2020 Mar; 58(4):527-532. PubMed ID: 31874093 [TBL] [Abstract][Full Text] [Related]
20. Identification and Use of Personalized Genomic Markers for Monitoring Circulating Tumor DNA. Chen Y; George AM; Olsson E; Saal LH Methods Mol Biol; 2018; 1768():303-322. PubMed ID: 29717450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]